Browse All
Displaying 1 - 1 of 1
Author:Banwell, Brenda Kotulska, Katarzyna Rostásy, Kevin Deiva, Kumaran Sato, Henry Filippi, Massimo Chitnis, Tanuja Sormani, Maria Pia Krupp, Lauren Bar-Or, Amit Evershed, Joanna El Azzouzi, Bouchra Wang, Qing Lin, Chien-Ju Hogea, Alexandra Schneble, Hans-Martin Manlius, Corinne Waubant, Emmanuelle
Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence
Topic:Multiple Sclerosis
Program Number:S40.005
Author Institution:Department of Pediatrics, Johns Hopkins University, Baltimore, MD, USA, Baltimore, MD Department of Neurology and Epileptology, The Children’s Memorial Health Institute, Warsaw, Poland, Warsaw, Poland Pediatric Neurology at Children's Hospital, Datteln, Germany, Datteln, Germany Department of Pediatrics Neurology, Bicêtre Hospital, Le Kremlin-Bicêtre, France and Paris Sud-Saclay University, Le Kremlin-Bicêtre, France, Le Kremlin-Bicêtre, France Neurological Institute of Curitiba, Curitiba, PR, Brazil, Curitiba, PR, Brazil Neuroimaging Research Unit, Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University, Milan, Italy, Milan, Italy Department of Pediatric Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA and Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, Boston, MA DISSAL, University of Genoa, Genoa, Italy, Genoa, Italy Department of Neurology, NYU Langone Health, New York, NY, USA, New York, NY Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland Neurology, University of California San Francisco, San Francisco, CA, USA, San Francisco, CA